-

Rosen Law Firm Urges Mullen Automotive, Inc. (NASDAQ: MULN) Stockholders to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of Mullen Automotive, Inc. (NASDAQ: MULN) between February 3, 2023 and March 13, 2024. Mullen describes itself as an “electronic vehicle manufacturer.”

For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.

The Allegations: Rosen Law Firm is Investigating the Allegations that Mullen Automotive, Inc. (NASDAQ: MULN) Misled Investors Regarding its Business Operations.

According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) Mullen had no intent of implementing a reverse stock split when in-fact the Chief Executive Officer David Michery (“CEO” or “Michery”), and Mullen believed one was imminent and necessary; (2) Mullen overstates its deals with business partners, including Rapid Response Defense Systems (“RRDS”) and Mullen Advanced Energy Operations, LLC (“MAEO”); (3) Mullen overstates its battery technology capabilities and partnerships (i.e., Lawrence Hardge related allegations); (4) Mullen misled the investing public about its reverse splits; (5) Mullen and Michery knew or should have known about Lawrence Hardge’s previous convictions for financial crimes and moral turpitude and disclosed this information to investors; (6) Mullen failed to disclose material information about its financing agreements; and (7) as a result, defendants’ public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

What Now: You may be eligible to participate in the class action against Mullen Automotive, Inc. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by April 14, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Rosen Law Firm: Some law firms issuing releases about this matter do not actually litigate securities class actions. Rosen Law Firm does. Rosen Law Firm is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses, improving corporate governance structures, and holding company executives accountable for their wrongdoing. Since its inception, Rosen Law Firm has obtained over $1 billion for shareholders.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com

Rosen Law Firm

NASDAQ:MULN

Release Versions

Contacts

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com

More News From Rosen Law Firm

Rosen Law Firm Urges Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) between October 31, 2022, and August 2, 2024. Actinium describes itself as a “late-stage biopharmaceutical company that develops targeted radiotherapies.” For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen...

GO Deadline with Expanded Class Period: Rosen Law Firm Urges Grocery Outlet Holding Corp. (NASDAQ: GO) Stockholders with Losses to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors we have filed a class action with an expanded class period on behalf of purchasers of securities of Grocery Outlet Holding Corp. (NASDAQ: GO) between August 9, 2023 and October 29, 2024. Grocery Outlet describes itself as a “value retailer of consumables and fresh products sold via a network of independently operated stores across the United States.” For more information, submit a form, email attorne...

TIXT Deadline: Rosen Law Firm Urges TELUS International (Cda) Inc. (NYSE: TIXT) Stockholders with Losses to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers and acquirers of securities of TELUS International (Cda) Inc. (NYSE: TIXT) between February 16, 2023 and August 1, 2024. TELUS International describes itself as a company that “purports to design, build, and deliver digital solutions for customer experience, including artificial intelligence ('AI') services, cloud solutions, and user exp...
Back to Newsroom